TD SYNNEX director sells 5,000 shares

TD SYNNEX director Richard T. Hume reported selling 5,000 shares of common stock in a series of open-market transactions on March 2, 2026.

Accepted by SEC EDGAR 03/03/2026 - 05:24 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

TD SYNNEX director Richard T. Hume reported selling 5,000 shares of common stock in a series of open-market transactions on March 2, 2026. The sales occurred at prices from $152.98 to $157.10 per share.

The transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on July 14, 2025. After these sales, Hume directly owns 37,515 shares of TD SYNNEX common stock.

Insider Trade Summary

Net Seller: 5,000 shares

Net Sell 6 txns

Insider HUME RICHARD T

Role Director

Sold 5,000 shs ($778K)

Share of Position Sold 11.8%

Type	Security	Shares	Price	Value
Sale	Common Stock	72	$152.98	$11K
Sale	Common Stock	373	$153.60	$57K
Sale	Common Stock	1,185	$154.42	$183K
Sale	Common Stock	1,080	$155.40	$168K
Sale	Common Stock	2,088	$156.46	$327K
Sale	Common Stock	202	$157.10	$32K

Holdings After Transaction: Common Stock — 37,515 shares (Direct)

Holdings Before and After: Common Stock, 42,515 to 37,515 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (6)

1. F1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2025.
2. F2. Represents the weighted average sales price for a number of transactions effected at prices ranging from $153.01 to $153.97. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
3. F3. Represents the weighted average sales price for a number of transactions effected at prices ranging from $154.03 to $154.97. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
4. F4. Represents the weighted average sales price for a number of transactions effected at prices ranging from $155.055 to $155.87. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
5. F5. Represents the weighted average sales price for a number of transactions effected at prices ranging from $156.01 to $156.98. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
6. F6. Represents the weighted average sales price for a number of transactions effected at prices ranging from $157.00 to $157.19. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did TD SYNNEX (SNX) report for Richard T. Hume?

TD SYNNEX reported that director Richard T. Hume sold 5,000 shares of common stock. The Form 4 shows multiple open-market sales on March 2, 2026, executed in several tranches at prices between $152.98 and $157.10 per share.

On what date did Richard T. Hume sell TD SYNNEX (SNX) shares and at what prices?

Richard T. Hume sold TD SYNNEX shares on March 2, 2026. The Form 4 lists several open-market sales, with transaction prices ranging from $152.98 to $157.10 per share across six separate trades in the company’s common stock.

How many TD SYNNEX (SNX) shares does Richard T. Hume own after the reported sales?

After the reported sales, Richard T. Hume directly owns 37,515 TD SYNNEX common shares. The Form 4 transaction table shows this balance as the total shares following the final March 2, 2026 open-market sale reported in the filing.

Were Richard T. Hume’s TD SYNNEX (SNX) stock sales under a Rule 10b5-1 plan?

Yes. A footnote states the sales were executed pursuant to a Rule 10b5-1 trading plan. The trading plan was adopted by Richard T. Hume on July 14, 2025, providing a pre-arranged framework for the March 2, 2026 stock sales.

What type of transactions did Richard T. Hume execute in TD SYNNEX (SNX) stock?

The filing describes the transactions as open-market sales of common stock. Each entry carries transaction code “S,” defined as a sale in an open market or private transaction, with all six trades reducing Hume’s directly held TD SYNNEX share balance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HUME RICHARD T

(Last) (First) (Middle)

5350 TECH DATA DRIVE

(Street)

CLEARWATER FL 33760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		S(1)		72	D	$152.98	42,443	D
Common Stock	03/02/2026		S(1)		373	D	$153.6(2)	42,070	D
Common Stock	03/02/2026		S(1)		1,185	D	$154.42(3)	40,885	D
Common Stock	03/02/2026		S(1)		1,080	D	$155.4(4)	39,805	D
Common Stock	03/02/2026		S(1)		2,088	D	$156.46(5)	37,717	D
Common Stock	03/02/2026		S(1)		202	D	$157.1(6)	37,515	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2025.

2. Represents the weighted average sales price for a number of transactions effected at prices ranging from $153.01 to $153.97. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

3. Represents the weighted average sales price for a number of transactions effected at prices ranging from $154.03 to $154.97. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

4. Represents the weighted average sales price for a number of transactions effected at prices ranging from $155.055 to $155.87. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

5. Represents the weighted average sales price for a number of transactions effected at prices ranging from $156.01 to $156.98. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

6. Represents the weighted average sales price for a number of transactions effected at prices ranging from $157.00 to $157.19. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

Remarks:

	/s/ Cheryl Grant, attorney-in-fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.